PUBLISHER: IMARC | PRODUCT CODE: 1746713
PUBLISHER: IMARC | PRODUCT CODE: 1746713
Japan vascular closure devices market size reached USD 92.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 161.0 Million by 2033, exhibiting a growth rate (CAGR) of 6.4% during 2025-2033. The growing healthcare sector, elevated occurrence of cardiovascular disorders, and a rising need for efficient blood loss management in patients are among the primary factors propelling the market growth.
Vascular closure devices (VCDs) are employed in medical facilities worldwide, including hospitals, clinics, specialty centers, and ambulatory surgery centers. They serve the crucial purpose of promptly sealing the small puncture created in an artery following an angiogram procedure. These devices find extensive usage, particularly among patients undergoing catheterization through the femoral route, in comparison to traditional mechanical compression methods. Additionally, they are beneficial in scenarios involving patients with a larger body build and those undergoing anticoagulation and antiplatelet therapies. These devices aid in reducing the time required for achieving hemostasis, enabling patients to mobilize more quickly, alleviating patient discomfort associated with prolonged bed rest, shortening hospital stays, and preventing complications related to the femoral artery. Consequently, there is an increasing demand for VCDs in the healthcare industry.
The expanding healthcare sector constitutes a significant driving force behind market growth in Japan. Additionally, there is a growing demand for catheterization and interventional procedures to diagnose and treat CVDs, creating attractive growth prospects for industry stakeholders. Moreover, the surging need for advanced surgical equipment in hospitals and surgical centers is exerting a positive impact on the market. Furthermore, the preference for femoral access in vascular procedures during coronary angiography and other interventions is on the rise globally. This preference, coupled with an increasing demand for non-invasive procedures to minimize sutures and scarring, is contributing positively to market growth. Furthermore, healthcare professionals are placing a greater emphasis on effective blood loss management in patients undergoing surgical procedures, further strengthening market expansion. Additionally, key manufacturers within the industry are concentrating on the production of large-bore vascular closure devices. This aligns with the growing number of registrations for innovative devices by prominent market players, which is accelerating market growth. Furthermore, there is increasing awareness among the general public regarding the advantages of VCDs, including facilitating minimally invasive procedures, achieving favorable patient outcomes, enabling early ambulation, and enhancing comfort during medical interventions. This heightened awareness is expected to catalyze the market growth over the forecasted period.